Literature DB >> 29353378

Secular trends in the appropriateness of empirical antibiotic treatment in patients with bacteremia: a comparison between three prospective cohorts.

Vered Daitch1,2,3,4, Yulia Akayzen5, Yasmin Abu-Ghanem5, Noa Eliakim-Raz6,5, Mical Paul7,8, Leonard Leibovici9,6,5, Dafna Yahav6,10.   

Abstract

The objective of this study was to explore whether the percentage of inappropriate empirical antibiotic treatment in patients with bacteremia changed over time and to understand the factors that brought on the change. Three prospective cohorts of patients with bacteremia in three different periods (January 1st, 1988 to December 31st, 1989; May 1st, 2004 to November 30, 2004; May 1st, 2010 to April 30, 2011) were compared. Analysis was performed on a total of 811 patients. In 2010-2011, 55.9% (76/136) of patients with bacteremia received inappropriate empirical treatment, compared with 34.5% (170/493) and 33.5% (55/164) in the first and second periods, respectively, in a significant upward trend (p = 0.001). Resistance to antibiotics increased significantly during the study period. The following variables were included in the multivariate analysis assessing risk factors for inappropriate empirical treatment: study period (third period) [odds ratio, OR = 2.766 (95% confidence interval, CI, 1.655-4.625)], gender (male) [OR = 1.511 (1.014-2.253)], pathogen carrying extended-spectrum beta-lactamases [OR = 10.426 (4.688-23.187)], multidrug-resistant Acinetobacter baumannii [OR = 5.428 (2.181-13.513)], and skin/soft infections [OR = 3.23 (1.148-9.084)]. A model excluding microbiological data included: gender (male) [OR = 1.648 (1.216-2.234)], study period (third period) [OR = 2.446 (1.653-3.620)], hospital-acquired infection [OR = 1.551 (1.060-2.270)], previous use of antibiotics [OR = 1.815 (1.247-2.642)], bedridden patient [OR = 2.019 (1.114-3.658)], and diabetes mellitus [OR = 1.620 (1.154-2.274)]. We have observed a worrisome increase in the rate of inappropriate empirical treatment of bacteremia. We need tools that will allow us better prediction of the pathogen and its susceptibilities during the first hours of managing a patient suspected of a severe bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29353378     DOI: 10.1007/s10096-018-3190-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  A two-year analysis of risk factors and outcome in patients with bloodstream infection.

Authors:  Andrea Endimiani; Antonio Tamborini; Francesco Luzzaro; Gianluigi Lombardi; Antonio Toniolo
Journal:  Jpn J Infect Dis       Date:  2003-02       Impact factor: 1.362

2.  An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: incidence, risk factors and its impact on outcome.

Authors:  Prashant Nasa; Deven Juneja; Omender Singh; Rohit Dang; Akhilesh Singh
Journal:  Eur J Intern Med       Date:  2011-07-30       Impact factor: 4.487

3.  Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.

Authors:  Mitchell J Schwaber; Shiri Navon-Venezia; Keith S Kaye; Ronen Ben-Ami; David Schwartz; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 4.  Strategies and challenges of antimicrobial stewardship in long-term care facilities.

Authors:  O J Dyar; L Pagani; C Pulcini
Journal:  Clin Microbiol Infect       Date:  2014-10-29       Impact factor: 8.067

5.  Patients at risk for inappropriate antibiotic treatment of bacteraemia.

Authors:  L Leibovici; H Konisberger; S D Pitlik; Z Samra; M Drucker
Journal:  J Intern Med       Date:  1992-04       Impact factor: 8.989

6.  Risk Factors for and Outcomes of Bacteremia Caused by Extended-Spectrum ß-Lactamase-Producing Escherichia coli and Klebsiella Species at a Canadian Tertiary Care Hospital.

Authors:  My-Linh Nguyen; Baldwin Toye; Salmaan Kanji; Rosemary Zvonar
Journal:  Can J Hosp Pharm       Date:  2015 Mar-Apr

7.  Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy.

Authors:  M Suppli; R Aabenhus; Z B Harboe; L P Andersen; M Tvede; J-U S Jensen
Journal:  Clin Microbiol Infect       Date:  2010-12-03       Impact factor: 8.067

8.  Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay.

Authors:  Abigail Fraser; Mical Paul; Nadja Almanasreh; Evelina Tacconelli; Uwe Frank; Roberto Cauda; Sara Borok; Michal Cohen; Steen Andreassen; Anders D Nielsen; Leonard Leibovici
Journal:  Am J Med       Date:  2006-11       Impact factor: 4.965

9.  Multidrug-resistant organism infections in US nursing homes: a national study of prevalence, onset, and transmission across care settings, October 1, 2010-December 31, 2011.

Authors:  Daver Kahvecioglu; Kalpana Ramiah; Darcy McMaughan; Steven Garfinkel; Veronica E McSorley; Quy Nhi Nguyen; Manshu Yang; Christopher Pugliese; David Mehr; Charles D Phillips
Journal:  Infect Control Hosp Epidemiol       Date:  2014-10       Impact factor: 3.254

10.  Antibiotic use in the care home setting: a retrospective cohort study analysing routine data.

Authors:  Pär-Daniel Sundvall; Beth Stuart; Martin Davis; Paul Roderick; Michael Moore
Journal:  BMC Geriatr       Date:  2015-06-25       Impact factor: 3.921

View more
  3 in total

1.  An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality.

Authors:  Ritvan Kara Ali; Serkan Surme; Ilker Inanc Balkan; Ayse Salihoglu; Meryem Sahin Ozdemir; Yusuf Ozdemir; Bilgul Mete; Gunay Can; Muhlis Cem Ar; Fehmi Tabak; Nese Saltoglu
Journal:  Ann Hematol       Date:  2020-06-20       Impact factor: 3.673

Review 2.  Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat.

Authors:  William Gustavo Lima; Mara Cristina Alves; Waleska Stephanie Cruz; Magna Cristina Paiva
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-09       Impact factor: 3.267

3.  Early Intravenous Colistin Therapy as a Favorable Prognostic Factor for 28-day Mortality in Patients with CRAB Bacteremia: a Multicenter Propensity Score-Matching Analysis.

Authors:  Tark Kim; Ki Ho Park; Shi Nae Yu; Seong Yeon Park; Se Yoon Park; Yu Mi Lee; Min Hyok Jeon; Eun Ju Choo; Tae Hyong Kim; Mi Suk Lee; EunJung Lee
Journal:  J Korean Med Sci       Date:  2019-10-14       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.